Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    18094377 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed MMF, Daclizumab and Corticosteroids as Mainstay Immunosuppression in Renal Transplant Patients
Condition: Kidney Transplantation
Intervention: Drug: daclizumab

Indicates status has not been verified in more than two years